TipRanks
Viking Therapeutics (DE:1VT)
XETRA:1VT
Germany Market
1VT
Viking Therapeutics
RESEARCH TOOLSreports

Viking Therapeutics (1VT) Balance Sheet

76 Followers

Viking Therapeutics Balance Sheet

Viking Therapeutics's total assets for Q2 2026 were $521.90M, a decrease of -14.20% from the previous quarter. DE:1VT total liabilities were $113.58M for the fiscal quarter, a 6.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 715.73M$ 908.32M$ 368.49M$ 168.53M$ 210.66M
Total Liabilities
$ 76.67M$ 28.04M$ 20.07M$ 23.21M$ 8.78M
Total Equity Gross Minority
$ 639.06M$ 880.28M$ 348.42M$ 145.32M$ 201.88M
Other Metrics
Currency in USD

Viking Therapeutics Debt to Assets